TGF-β induces fibronectin synthesis through a C-jun N-terminal kinase-dependent, Smad4-independent pathway

EMBO Journal

Volumn 18, Issue 5, 1999, Pages 1345-1356

  Hocevar, Barbara A ^a   Brown, Thomas L ^a   Howe, Philip H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cJun; cJun N terminal kinase (JNK); Fibronectin; Smad4; Transforming growth factor (TGF )

Indexed keywords

FIBRONECTIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PLASMINOGEN ACTIVATOR INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; FIBROSARCOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBRONECTINS; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0033104505     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Abdollah, S., Macias-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L. and Wrana, J.L. (1997) TßRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem., 272, 27678-27685.
2. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. and Saltiel, A.R. (1995) PD 98059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494.
3. Angel, P. and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072, 129-157.
4. Angel, P., Hattori, K., Smeal, T. and Karin, M. (1988) The jun protooncogene is positively autoregulated by its product, Jun/AP-1. Cell, 55, 875-885.
5. Atfi, A., Buisine, M., Mazars, A. and Gespach, C. (1997a) Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-β through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J. Biol. Chem., 272, 24731-24734.
6. Atfi, A., Djelloul, S., Chastre, E., Davis, R. and Gespach, C. (1997b) Evidence for a role of Rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J. Biol. Chem., 272, 1429-1432.
7. Border, W.A. and Noble, N.A. (1994) Transforming growth factor β in tissue fibrosis. N. Engl. J. Med., 331, 1286-1292.
8. Bowlus, C.L., McQuillan, J.J. and Dean, D.C. (1991) Characterization of three different elements in the 5′-flanking region of the fibronectin gene which mediate a transcriptional response to cAMP. J. Biol. Chem., 266, 1122-1127.
9. Campbell, C.E., Flenniken, A.M., Skup, D. and Williams, B.R.G. (1991) Identification of a serum- and phorbol ester-responsive element in the murine tissue inhibitor of metalloproteinase gene. J. Biol. Chem., 266, 7199-7206.
10. Carcamo, J., Zentella, A. and Massagué, J. (1995) Disruption of transforming growth factor β signaling by a mutation that prevents transphosphorylation within the receptor complex. Mol. Cell. Biol., 15, 1573-1581.
11. Chen, X., Rubock, M.J. and Whitman, M. (1996) A transcriptional partner for MAD proteins in TGF-β signalling. Nature, 383, 691-696.
12. Chung, K.Y., Agarwal, A., Uitto, J. and Mauviel, A. (1996) An AP-1 binding sequence is essential for regulation of the human α2 (I) collagen (COL1A2) promoter activity by transforming growth factor-β. J. Biol. Chem., 271, 3272-3278.
13. Cohen, P. (1997) The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol., 7, 353-361.
14. Coito, A.J., Binder, J., Brown, L.F., de Sousa, M., Van de Water, L. and Kupiec-Weglinski, J.W. (1995) TNF-α upregulates the expression of fibronectin in acutely rejecting rat cardiac allografts. Transplant. Proc., 27, 463-465.
15. Danielson, P.E., Forss-Petter, S., Brow, M.A., Calavetta, L., Douglass, J., Milner, R.J. and Sutcliffe, J.G. (1988) p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA, 7, 261-267.
16. Dean, D.C., Bowlus, C.L. and Bourgeois, S. (1987) Cloning and analysis of the promoter region of the human fibronectin gene. Proc. Natl Acad. Sci. USA, 84, 1876-1880.
17. Dean, D.C., Newby, R.F. and Bourgeois, S. (1988) Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor β and cAMP in human cell lines. J. Cell Biol., 106, 2159-2170.
18. Dean, D.C., Blakely, M.S., Newby, R.F., Ghazal, P., Hennighausen, L. and Bourgeois, S. (1989) Forskolin inducibility and tissue-specific expression of the fibronectin promoter. Mol. Cell. Biol., 9, 1498-1506.
19. Dean, D.C., McQuillan, J.J. and Weintraub, S. (1990) Serum stimulation of fibronectin gene expression appears to result from rapid serum-induced binding of nuclear proteins to a cAMP response element. J. Biol. Chem., 265, 3522-3527.
20. De Cesare, D., Vallone, D., Caracciolo, A., Sassone-Corsi, P., Nerlov, C. and Verde, P. (1995) Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene, 11, 365-376.
21. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S. and Gauthier, J.-M. (1998) Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J., 17, 3091-3100.
22. Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M. and Davis, R.J. (1994) JNKI: a protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-jun activation domain. Cell, 76, 1025-1037.
23. Derijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R.J. and Davis, R.J. (1995) Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science, 267, 682-685.
24. Descheemaeker, K.A., Wyns, S., Nelles, L., Auwerx, J., Ny, T. and Collen, D. (1992) Interaction of AP-1-, AP-2- and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response. J. Biol. Chem., 267, 15086-15091.
25. de Winter, J.P., Roelen, B.A., ten Dijke, P., van der Burg, B. and van den Eijnden-van Raaij, A.J. (1997) DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene. 14, 1891-1899.
26. Du, W., Thanos, D. and Maniatis, T. (1993) Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell, 74, 887-898.
27. Farhadian, F., Contard, F., Corbier, A., Barrieux, A., Rappaport, L. and Samuel, J.L. (1995) Fibronectin expression during physiological and pathological cardiac growth. J. Mol. Cell. Cardiol., 27, 981-990.
28. Frey, R.S. and Mulder, K.M. (1997) Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor β in the negative growth control of breast cancer cells. Cancer Res., 57, 628-633.
29. George, E.L., Georges-Labouesse, E.N., Patel-King, R.S., Rayburn, H. and Hynes, R.O. (1993) Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development, 119, 1079-1091.
30. Greiling, D. and Clark, R.A.F. (1997) Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J. Cell Sci., 110, 861-870.
31. Gupta, S., Campbell, D., Derijard, B. and Davis, R.J. (1995) Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science, 267, 389-393.
32. Gupta, S., Barrett, T., Whitmarsh, A.J., Cavanagh, J., Sluss, H.K., Derijard, B. and Davis, R.J. (1996) Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J., 15, 2760-2770.
33. Hai, T. and Curran, T. (1991) Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl Acad. Sci. USA, 88, 3720-3724.
34. Hannigan, M., Zhan, L., Ai, Y. and Huang, C.-K. (1998) The role of p38 MAP kinase in TGF-β-1-induced signal transduction in human neutrophils. Biochem. Biophys. Res. Commun., 246, 55-58.
35. Hartsough, M.T. and Mulder, K.M. (1995) Transforming growth factor β activation of p44mapk in proliferating cultures of epithelial cells. J. Biol. Chem., 270, 7117-7124.
36. Heldin, C.H., Miyazono, K. and ten Dijke, P (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465-471.
37. Hibi, M., Lin, A., Smeal, T., Minden, A. and Karin, M. (1993) Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev., 7, 2135-2148.
38. Hocevar, B.A. and Howe, P.H. (1996) Isolation and characterization of mutant cell lines defective in transforming growth factor β signaling. Proc. Natl Acad. Sci. USA, 93, 7655-7660.
39. Hua, X., Liu, X., Ansari, D.O. and Lodish, H.F. (1998) Synergistic cooperation of TFE3 and Smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev., 12, 3084-3095.
40. Hynes, R. (1985) Molecular biology of fibronectin. Annu. Rev. Cell Biol., 1, 67-90.
41. Ignotz, R.A. and Massagué, J. (1986) Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem., 261, 4337-4345.
42. Iordanov, M., Bender, K., Ade, T., Schmid, W., Sachsenmaier, C., Engel, K., Gaestel, M., Rahmsdorf, H.J. and Herrlich, P. (1997) CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J., 16, 1009-1022.
43. Jiang, Y., Chen, C., Li, Z., Guo, W., Gegner, J.A., Lin, S. and Han, J. (1996) Characterization of the structure and function of a new mitogen-activated protein kinase (p38β). J. Biol. Chem., 271, 17920-17926.
44. Jin, G. and Howe, P.H. (1998) Regulation of clusterin gene expression by transforming growth factor β. J. Biol. Chem., 272, 26620-26626.
45. Jvashkiv, L.B., Liou, H.-C., Kara, C.J., Lamph, W.W., Verma, I.M. and Glimcher, L.H. (1990) mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoyl-phorbol-13-acetate, response element. Mol. Cell. Biol., 10, 1609-1621.
46. Karin, M. and Smeal, T. (1992) Control of transcription factors by signal transduction pathways: the beginning of the end. Trends. Biochem. Sci., 17, 418-422.
47. Keeton, M.R., Curriden, S.A., van Zonneveld, A.J. and Loskutoff, D.J. (1991) Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor β. J. Biol. Chem., 266, 23048-23052.
48. Kim, S.-J., Angel, P., Lafyatis, R., Hattori, K., Kim, K.Y., Sporn, M.B., Karin, M. and Roberts, A.B. (1990) Autoinduction of transforming growth factor β 1 is mediated by the AP-1 complex. Mol. Cell. Biol., 10, 1492-1497.
49. Kim, S.-J., Wagner, S., Liu, F., O'Reilly, M.A., Robbins, P.D. and Green, M.R. (1992) Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature, 358, 331-334.
50. Kornblihtt, A.R., Vibe-Pedersen, K. and Baralle, F.E. (1983) Isolation and characterization of cDNA clones for human and bovine fibronectins. Proc. Natl Acad. Sci. USA, 80, 3218-3222.
51. Kornblihtt, A.R., Pesce, C.G., Alonso, C.R., Cramer, P., Srebrow, A., Werbajh, S. and Muro, A.F. (1996) The fibronectin gene as a model for splicing and transcription studies. FASEB J., 10, 248-257.
52. Kyriakis, J.M. and Avruch, J. (1996) Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem., 271, 24313-24316.
53. Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.F., Avruch, J. and Woodgett, J.R. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature, 369, 156-160.
54. Labbe, E., Silvestri, C., Hoodless, P.A., Wrana, J.L. and Attisano, L. (1998) Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell, 2, 109-120.
55. Le Dai, J., Turnacioglu, K.K., Schutte, M., Sugar, A.Y. and Kern, S.E. (1998) Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res., 58, 4592-4597.
56. Lee, Y.J. et al. (1997) TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol., 158, 2065-2075.
57. Leof, E.B., Proper, J.A., Getz, M.J. and Moses, H.L. (1986) Transforming growth factor type β regulation of actin mRNA. J. Cell Physiol., 127, 83-88.
58. Li, J.M., Shen, X., Hu, P.P.-C. and Wang, X.-F. (1998) Transforming growth factor β stimulates the human immunodeficiency virus 1 enhancer and requires NF-κB activity. Mol. Cell. Biol., 18, 110-121.
59. Lin, A., Minden, A., Martinetto, H., Claret, F.-X., Lange-Carter, C., Mercurio, F., Johnson, G.L. and Karin, M. (1995) Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science, 268, 286-290.
60. Liu, X., Sun, Y., Constantinescu, S.N., Karam, E., Weinberg, R.A. and Lodish, H.L. (1997) Transforming growth factor β-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl Acad. Sci. USA, 94, 10669-10674.
61. Marais, R. and Marshall, C.J. (1996) Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv., 27, 101-125.
62. Martin, P. (1997) Wound healing - aiming for perfect skin regeneration. Science, 276, 75-81.
63. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol., 6, 597-641.
64. Massagué, J. (1998) TGF-β signal transduction. Annu. Rev. Biochem., 67, 753-791.
65. Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R.J., Johnson, G.L. and Karin, M. (1994) Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science, 266, 1719-1722.
66. Molossi, S., Clausell, N. and Rabinovitch, M. (1995) Reciprocal induction of tumor necrosis factor-α and interleukin-1β activity mediates fibronectin synthesis in coronary artery smooth muscle cells. J. Cell Physiol., 163, 19-29.
67. Moriguchi, T., Toyoshima, F., Masuyama, N., Hanafusa, H., Gotoh, Y. and Nishida, E. (1997) A novel SAPK/JNK kinase, MKK7, stimulated by TNFα and cellular stress. EMBO J., 16, 7045-7053.
68. Pertovaara, L., Sistonen, L., Bos, T.J., Vogt, P.K., Keski-Oja, J. and Alitalo, K. (1989) Enhanced jun gene expression is an early genomic response to transforming growth factor β stimulation. Mol. Cell. Biol., 9, 1255-1262.
69. Raingeaud, J., Gupta, S., Rogers, J.S., Dickens, M., Han, J., Ulevitch, R. and Davis, R.J. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem., 270, 7420-7426.
70. Rasmussen, L.M., Wolf, Y.G. and Ruoslahti, E. (1995) Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-β activity. Am. J. Pathol., 147, 1041-1048.
71. Read, M.A., Whitley, M.Z., Gupta, S., Pierce, J.W., Best, J., Davis, R.J. and Collins, T. (1997) Tumor necrosis factor α-induced E-selectin expression is activated by the nuclear factor-κB and c-Jun N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem., 272, 2753-2761.
72. Roberts, A.B. and Sporn, M.B. (1990) The transforming growth factor-βs. In Sporn, M. and Roberts, A.B. (eds), Peptide Growth Factors and Their Receptors. Springer, Heidelberg, Germany, pp. 419-472.
73. Schutte, M. et al. (1996) DPC4 in various tumor types. Cancer Res., 56, 2527-2530.
74. Serini, G., Bochaton-Piallat, M.-L., Ropraz, P., Geinoz, A., Borsi, L., Zardi, L. and Gabbiani, G. (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-β1. J. Cell Biol., 142, 873-881.
75. Shino, Y., Shirasawa, H., Kinoshita, T. and Simizu, B. (1997) Human papillomavirus type 16 E6 protein transcriptionally modulates fibronectin gene expression by induction of protein complexes binding to the cyclic AMP response element. J. Virol., 71, 4310-4318.
76. Shirakabe, K., Yamaguchi, K., Shibuya, H., Irie, K., Matsuda, S., Moriguchi, T., Gotoh, Y., Matsumoto, K. and Nishida, E. (1997) TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem., 272, 8141-8144.
77. Sluss, H.K., Barrett, T., Derijard, B. and Davis, R.J. (1994) Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol., 14, 8376-8384.
78. Song, C.-Z., Siok, T.E. and Gelehrter, T.D. (1998) Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β-responsive element in the human plasminogen activator inhibitor-1 promoter. J. Biol. Chem., 273, 29287-29290.
79. Souchelnytskyi, S., Tamaki, K., Engstrom, U., Wernstedt, C., ten Dijke, P. and Heldin, C-H. (1997) Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol. Chem., 272, 28107-28115.
80. Tong, L., Pav, S., White, D.M., Rogers, S., Crane, K.M., Cywin, C.L., Brown, M.L. and Pargellis, C.A. (1997) A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nature Struct. Biol., 4, 311-316.
81. 2-terminal kinase. Proc. Natl Acad. Sci. USA, 94, 7337-7342.
82. Treisman, R. (1996) Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol., 8, 205-215.
83. van Dam, H., Duyndam, M., Rottier, R., Bosch, A., de Vries-Smits, L., Herrlich, P. Zantema, A., Angel, P. and van der Eb, A.J. (1993) Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid E1A protein. EMBO J., 12, 479-487.
84. Villanueva, A. et al. (1998) Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells. Oncogene, 17, 1969-1978.
85. Wang, W., Zhou, G., Hu, M.C.T., Yao, Z. and Tan, T.H. (1997) Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor β (TGF-β)-activated kinase (TAK1), a kinase mediator of TGF-β signal transduction, J. Biol. Chem., 272, 22771-22775.
86. Westerhausen, D.R., Jr. Hopkins, W.E. and Billadello, J.J. (1991) Multiple transforming growth factor-β-inducible elements regulate expression of the plasminogen activator inhibitor type-1 gene in Hep G2 cells. J. Biol. Chem., 266, 1092-1100.
87. Whitman, M. (1997) Feedback from inhibitory SMADs. Nature, 389, 549-551.
88. Whitmarsh, A.J., Shore, P., Sharrocks, A.D. and Davis, R.J. (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science, 269, 403-407.
89. Woodgett, J.R., Avruch, J. and Kyriakis, J. (1996) The stress activated protein kinase pathway. Cancer Surv., 27, 127-138.
90. Wrana, J.L., Overall, C.M. and Sodek, J. (1991) Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β. Eur. J. Biochem., 197, 519-528.
91. Wrana, J.L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.F. and Massagué, J. (1992) TGF β signals through a heteromeric protein kinase receptor complex. Cell, 71, 1003-1014.
92. Wun, T.C. and Kretzmer, K.K. (1987) cDNA cloning and expression in E.coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by HepG2 hepatoma cell. FEBS Lett., 210, 11-16.
93. Xing, J., Ginty, D.D. and Greenberg, M.E. (1996) Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science, 273, 959-963.
94. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E. and Matsumoto, K. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science, 270, 2008-2011.
95. Yingling, J.M., Datto, M.B., Wong, C., Frederick, J.P., Liberati, N.T. and Wang, X.F. (1997) Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol., 17, 7019-7028.
96. Zhang, K., Rekhter, M.D., Gordon, D. and Phan, S.H. (1994) Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol., 145, 114-125.
97. Zhang, Y., Feng, X.-H., Wu, R.-Y. and Derynck, R. (1996) Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature, 383, 168-172.
98. Zhang, Y., Feng, X.-H. and Derynck, R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature, 394, 909-913.
99. Zhou, S., Buckhaults, P., Zawel, L., Bunz, F., Riggins, G., Le Dai, J., Kern, S.E., Kinzler, K.W. and Vogelstein, B. (1998) Targeted deletion of Smad4 shows it is required for transforming growth factor β and activin signaling in colorectal cancer cells. Proc. Natl Acad. Sci. USA, 95, 2412-2416.